PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice

Kumiko Torisu, Xueli Zhang, Mari Nonaka, Takahide Kaji, Daisuke Tsuchimoto, Kosuke Kajitani, Kunihiko Sakumi, Takehiro Torisu, Kazuhiro Chida, Katsuo Sueishi, Michiaki Kubo, Jun Hata, Takanari Kitazono, Yutaka Kiyohara, Yusaku Nakabeppu

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Genomewide association studies have shown that a nonsynonymous single nucleotide polymorphism in PRKCH is associated with cerebral infarction and atherosclerosis-related complications. We examined the role of PKCη in lipid metabolism and atherosclerosis using apolipoprotein E-deficient (Apoe−/−) mice. PKCη expression was augmented in the aortas of mice with atherosclerosis and exclusively detected in MOMA2-positive macrophages within atherosclerotic lesions. Prkch+/+Apoe−/− and Prkch−/−Apoe−/− mice were fed a high-fat diet (HFD), and the dyslipidemia observed in Prkch+/+Apoe−/− mice was improved in Prkch−/−Apoe−/− mice, with a particular reduction in serum LDL cholesterol and phospholipids. Liver steatosis, which developed in Prkch+/+Apoe−/− mice, was improved in Prkch−/−Apoe−/− mice, but glucose tolerance, adipose tissue and body weight, and blood pressure were unchanged. Consistent with improvements in LDL cholesterol, atherosclerotic lesions were decreased in HFD-fed Prkch−/−Apoe−/− mice. Immunoreactivity against 3-nitrotyrosine in atherosclerotic lesions was dramatically decreased in Prkch−/−Apoe−/− mice, accompanied by decreased necrosis and apoptosis in the lesions. ARG2 mRNA and protein levels were significantly increased in Prkch−/−Apoe−/− macrophages. These data show that PKCη deficiency improves dyslipidemia and reduces susceptibility to atherosclerosis in Apoe−/− mice, showing that PKCη plays a role in atherosclerosis development.

Original languageEnglish
Pages (from-to)1030-1048
Number of pages19
JournalGenes to Cells
Volume21
Issue number10
DOIs
Publication statusPublished - Oct 1 2016

Fingerprint

Apolipoproteins E
Lipid Metabolism
Atherosclerosis
High Fat Diet
Dyslipidemias
LDL Cholesterol
Macrophages
Intracranial Arteriosclerosis
Cerebral Infarction
Fatty Liver
Single Nucleotide Polymorphism
Aorta
Adipose Tissue
Phospholipids
Necrosis
Body Weight
Apoptosis
Blood Pressure
Glucose
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Genetics
  • Cell Biology

Cite this

PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice. / Torisu, Kumiko; Zhang, Xueli; Nonaka, Mari; Kaji, Takahide; Tsuchimoto, Daisuke; Kajitani, Kosuke; Sakumi, Kunihiko; Torisu, Takehiro; Chida, Kazuhiro; Sueishi, Katsuo; Kubo, Michiaki; Hata, Jun; Kitazono, Takanari; Kiyohara, Yutaka; Nakabeppu, Yusaku.

In: Genes to Cells, Vol. 21, No. 10, 01.10.2016, p. 1030-1048.

Research output: Contribution to journalArticle

@article{05872771a71f49028e552d4e18a9ba29,
title = "PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice",
abstract = "Genomewide association studies have shown that a nonsynonymous single nucleotide polymorphism in PRKCH is associated with cerebral infarction and atherosclerosis-related complications. We examined the role of PKCη in lipid metabolism and atherosclerosis using apolipoprotein E-deficient (Apoe−/−) mice. PKCη expression was augmented in the aortas of mice with atherosclerosis and exclusively detected in MOMA2-positive macrophages within atherosclerotic lesions. Prkch+/+Apoe−/− and Prkch−/−Apoe−/− mice were fed a high-fat diet (HFD), and the dyslipidemia observed in Prkch+/+Apoe−/− mice was improved in Prkch−/−Apoe−/− mice, with a particular reduction in serum LDL cholesterol and phospholipids. Liver steatosis, which developed in Prkch+/+Apoe−/− mice, was improved in Prkch−/−Apoe−/− mice, but glucose tolerance, adipose tissue and body weight, and blood pressure were unchanged. Consistent with improvements in LDL cholesterol, atherosclerotic lesions were decreased in HFD-fed Prkch−/−Apoe−/− mice. Immunoreactivity against 3-nitrotyrosine in atherosclerotic lesions was dramatically decreased in Prkch−/−Apoe−/− mice, accompanied by decreased necrosis and apoptosis in the lesions. ARG2 mRNA and protein levels were significantly increased in Prkch−/−Apoe−/− macrophages. These data show that PKCη deficiency improves dyslipidemia and reduces susceptibility to atherosclerosis in Apoe−/− mice, showing that PKCη plays a role in atherosclerosis development.",
author = "Kumiko Torisu and Xueli Zhang and Mari Nonaka and Takahide Kaji and Daisuke Tsuchimoto and Kosuke Kajitani and Kunihiko Sakumi and Takehiro Torisu and Kazuhiro Chida and Katsuo Sueishi and Michiaki Kubo and Jun Hata and Takanari Kitazono and Yutaka Kiyohara and Yusaku Nakabeppu",
year = "2016",
month = "10",
day = "1",
doi = "10.1111/gtc.12402",
language = "English",
volume = "21",
pages = "1030--1048",
journal = "Genes to Cells",
issn = "1356-9597",
publisher = "Wiley-Blackwell",
number = "10",

}

TY - JOUR

T1 - PKCη deficiency improves lipid metabolism and atherosclerosis in apolipoprotein E-deficient mice

AU - Torisu, Kumiko

AU - Zhang, Xueli

AU - Nonaka, Mari

AU - Kaji, Takahide

AU - Tsuchimoto, Daisuke

AU - Kajitani, Kosuke

AU - Sakumi, Kunihiko

AU - Torisu, Takehiro

AU - Chida, Kazuhiro

AU - Sueishi, Katsuo

AU - Kubo, Michiaki

AU - Hata, Jun

AU - Kitazono, Takanari

AU - Kiyohara, Yutaka

AU - Nakabeppu, Yusaku

PY - 2016/10/1

Y1 - 2016/10/1

N2 - Genomewide association studies have shown that a nonsynonymous single nucleotide polymorphism in PRKCH is associated with cerebral infarction and atherosclerosis-related complications. We examined the role of PKCη in lipid metabolism and atherosclerosis using apolipoprotein E-deficient (Apoe−/−) mice. PKCη expression was augmented in the aortas of mice with atherosclerosis and exclusively detected in MOMA2-positive macrophages within atherosclerotic lesions. Prkch+/+Apoe−/− and Prkch−/−Apoe−/− mice were fed a high-fat diet (HFD), and the dyslipidemia observed in Prkch+/+Apoe−/− mice was improved in Prkch−/−Apoe−/− mice, with a particular reduction in serum LDL cholesterol and phospholipids. Liver steatosis, which developed in Prkch+/+Apoe−/− mice, was improved in Prkch−/−Apoe−/− mice, but glucose tolerance, adipose tissue and body weight, and blood pressure were unchanged. Consistent with improvements in LDL cholesterol, atherosclerotic lesions were decreased in HFD-fed Prkch−/−Apoe−/− mice. Immunoreactivity against 3-nitrotyrosine in atherosclerotic lesions was dramatically decreased in Prkch−/−Apoe−/− mice, accompanied by decreased necrosis and apoptosis in the lesions. ARG2 mRNA and protein levels were significantly increased in Prkch−/−Apoe−/− macrophages. These data show that PKCη deficiency improves dyslipidemia and reduces susceptibility to atherosclerosis in Apoe−/− mice, showing that PKCη plays a role in atherosclerosis development.

AB - Genomewide association studies have shown that a nonsynonymous single nucleotide polymorphism in PRKCH is associated with cerebral infarction and atherosclerosis-related complications. We examined the role of PKCη in lipid metabolism and atherosclerosis using apolipoprotein E-deficient (Apoe−/−) mice. PKCη expression was augmented in the aortas of mice with atherosclerosis and exclusively detected in MOMA2-positive macrophages within atherosclerotic lesions. Prkch+/+Apoe−/− and Prkch−/−Apoe−/− mice were fed a high-fat diet (HFD), and the dyslipidemia observed in Prkch+/+Apoe−/− mice was improved in Prkch−/−Apoe−/− mice, with a particular reduction in serum LDL cholesterol and phospholipids. Liver steatosis, which developed in Prkch+/+Apoe−/− mice, was improved in Prkch−/−Apoe−/− mice, but glucose tolerance, adipose tissue and body weight, and blood pressure were unchanged. Consistent with improvements in LDL cholesterol, atherosclerotic lesions were decreased in HFD-fed Prkch−/−Apoe−/− mice. Immunoreactivity against 3-nitrotyrosine in atherosclerotic lesions was dramatically decreased in Prkch−/−Apoe−/− mice, accompanied by decreased necrosis and apoptosis in the lesions. ARG2 mRNA and protein levels were significantly increased in Prkch−/−Apoe−/− macrophages. These data show that PKCη deficiency improves dyslipidemia and reduces susceptibility to atherosclerosis in Apoe−/− mice, showing that PKCη plays a role in atherosclerosis development.

UR - http://www.scopus.com/inward/record.url?scp=84989903817&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84989903817&partnerID=8YFLogxK

U2 - 10.1111/gtc.12402

DO - 10.1111/gtc.12402

M3 - Article

C2 - 27545963

AN - SCOPUS:84989903817

VL - 21

SP - 1030

EP - 1048

JO - Genes to Cells

JF - Genes to Cells

SN - 1356-9597

IS - 10

ER -